Missouri Trust & Investment Company’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $981K | Buy |
7,810
+1,485
| +23% | +$187K | 0.32% | 63 |
|
|
2025
Q1 | $866K | Buy |
6,325
+2,460
| +64% | +$337K | 0.3% | 67 |
|
|
2024
Q4 | $591K | Sell |
3,865
-777
| -17% | -$119K | 0.21% | 81 |
|
|
2024
Q3 | $900K | Buy |
4,642
+760
| +20% | +$147K | 0.31% | 65 |
|
|
2024
Q2 | $900K | Buy |
3,882
+50
| +1% | +$11.6K | 0.34% | 63 |
|
|
2024
Q1 | $826K | Buy |
3,832
+370
| +11% | +$79.8K | 0.32% | 67 |
|
|
2023
Q4 | $896K | Sell |
3,462
-210
| -6% | -$54.3K | 0.36% | 62 |
|
|
2023
Q3 | $944K | Buy |
3,672
+1,225
| +50% | +$315K | 0.42% | 49 |
|
|
2023
Q2 | $697K | Buy |
2,447
+180
| +8% | +$51.3K | 0.39% | 65 |
|
|
2023
Q1 | $630K | Sell |
2,267
-390
| -15% | -$108K | 0.41% | 66 |
|
|
2022
Q4 | $736K | Sell |
2,657
-2
| -0.1% | -$554 | 0.44% | 52 |
|
|
2022
Q3 | $710K | Sell |
2,659
-226
| -8% | -$60.3K | 0.46% | 48 |
|
|
2022
Q2 | $588K | Buy |
2,885
+260
| +10% | +$53K | 0.38% | 65 |
|
|
2022
Q1 | $553K | Buy |
2,625
+510
| +24% | +$107K | 0.32% | 67 |
|
|
2021
Q4 | $507K | Buy |
+2,115
| New | +$507K | 0.29% | 71 |
|